Filing Details
- Accession Number:
- 0001401708-21-000210
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-10 16:38:31
- Reporting Period:
- 2021-09-08
- Accepted Time:
- 2021-09-10 16:38:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1401708 | Nanostring Technologies Inc | NSTG | Biological Products, (No Disgnostic Substances) (2836) | 200094687 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1575739 | Bradley R Gray | 530 Fairview Avenue N Seattle WA 98109 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-09-08 | 12,500 | $6.72 | 169,158 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-09-08 | 14,975 | $56.86 | 154,183 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-09-08 | 17,959 | $58.79 | 136,224 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-09-08 | 400 | $58.79 | 135,824 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2021-09-08 | 12,500 | $6.72 | 12,500 | $6.72 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
12,500 | 2023-01-09 | No | 4 | M | Direct |
Footnotes
- The sales reported by Mr. Gray were effected pursuant to a Rule 10b5-1 trading plan adopted on September 15, 2020.
- The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $56.37 to $57.36, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $57.37 to $58.31, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The option is subject to an early exercise provision and is immediately exercisable. 1/48th of the shares subject to such Option shall vest on each monthly anniversary of January 10, 2013.